New research which may help men reduce their risk of prostate cancer is underway in Oxford, thanks to a major award from the World Cancer Research Fund.
Watch the video below to hear from Profesor Sir Rory Collins, speaking at the prestigious Gresham College in London on the opportunities and challenges in the vast amount of UK Biobank data.
POSTMENOPAUSAL WOMEN who do the highest amount of vigorous exercise could be around a fifth less likely to develop breast cancer than those who put their feet up, according to new findings being presented at the National Cancer Research Institute (NCRI) Cancer Conference.
Students for the new MSc Global Health Science and the DPhil in Population Health have arrived at the Nuffield Department of Population Health to begin their courses.
Scientists at the Health Services Research Unit (HSRU), Nuffield Department of Population Health, and Picker Institute Europe, have won a \u00a3305,000 grant to help improve the experience of people being treated in hospital wards and A&E departments.
Solving the large challenges facing healthcare systems around the world will require a huge shift in the way care for patients is provided, Professor Robyn Norton said in the first Oxford India Lecture on Monday 15 September.
New research published in The Lancet suggests that, with sustained international efforts, the number of premature deaths could be reduced by 40% over the next two decades (2010-2030), halving under\u201350 mortality and preventing a third of the deaths at ages 50\u201369 years.
Women living in the most deprived areas are less likely to have antenatal care and less likely to have a routine postnatal check, compared with women in more affluent areas.
Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness, according to new findings from the largest meta-analysis to date investigating the clot-busting drug alteplase.
Oxford University scientists have shown that a drug given at the time of a kidney transplant operation halves the risk of early rejection of the organ. The drug, called alemtuzumab, also allows a less toxic regimen of anti-rejection drugs to be used after the operation.
The Big Data in BioMedicine Conference was held at the Li Ka Shing Center for Learning and Knowledge on the Stanford University campus in May. Combining leading-edge medicine, technology and architecture, the center\u2019s conference facilities enabled experts from around the world to bring their expertise to bear on the great health challenges of our time.
![\"Dr](\"https://www.ndph.ox.ac.uk/news/major-charity-grant-paves-the-way-for-key-prostate-cancer-research/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n